Literature DB >> 19513899

Improved isolation protocol for equine cord blood-derived mesenchymal stromal cells.

Thomas G Koch1, Preben D Thomsen, Dean H Betts.   

Abstract

BACKGROUND AIMS: A robust methodology for the isolation of cord blood-derived multipotent mesenchymal stromal cells (CB-MSCs) from fresh umbilical cord blood has not been reported in any species. The objective of this study was to improve the isolation procedure for equine CB-MSCs.
METHODS: Pre-culture separation of red and white blood cells was done using either PrepaCyte?-EQ medium or Ficoll-Paque? PREMIUM density medium. Regular FBS and MSC-qualified FBS were compared for their ability to support the establishment of putative primary MSC colonies. RESULTS AND
CONCLUSIONS: Our results indicate that PrepaCyte-EQ medium is superior to Ficoll-Paque PREMIUM density medium for the isolation of putative equine CB MSC and that MSC-qualified FBS may improve the isolation efficiency.

Entities:  

Mesh:

Year:  2009        PMID: 19513899     DOI: 10.1080/14653240902887259

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  11 in total

1.  Umbilical cord as a mesenchymal stem cell source for treating joint pathologies.

Authors:  Maria Carmen Arufe; Alexandre De la Fuente; Isaac Fuentes; Francisco Javier De Toro; Francisco Javier Blanco
Journal:  World J Orthop       Date:  2011-06-18

2.  Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells().

Authors:  Danielle D Carrade; Michael W Lame; Michael S Kent; Kaitlin C Clark; Naomi J Walker; Dori L Borjesson
Journal:  Cell Med       Date:  2012-01-01

3.  Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells.

Authors:  Laurence Tessier; Dorothee Bienzle; Lynn B Williams; Thomas G Koch
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

4.  Post-thaw non-cultured and post-thaw cultured equine cord blood mesenchymal stromal cells equally suppress lymphocyte proliferation in vitro.

Authors:  Lynn B Williams; Laurence Tessier; Judith B Koenig; Thomas G Koch
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

5.  Chondrogenic Differentiation of Defined Equine Mesenchymal Stem Cells Derived from Umbilical Cord Blood for Use in Cartilage Repair Therapy.

Authors:  Mélanie Desancé; Romain Contentin; Lélia Bertoni; Tangni Gomez-Leduc; Thomas Branly; Sandrine Jacquet; Jean-Marc Betsch; Agnès Batho; Florence Legendre; Fabrice Audigié; Philippe Galéra; Magali Demoor
Journal:  Int J Mol Sci       Date:  2018-02-10       Impact factor: 5.923

Review 6.  Current Status of Canine Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Veterinary Medicine.

Authors:  Tania Sultana; Soojung Lee; Hun-Young Yoon; Jeong Ik Lee
Journal:  Stem Cells Int       Date:  2018-07-15       Impact factor: 5.443

7.  Biological behaviors of muscarinic receptors in mesenchymal stem cells derived from human placenta and bone marrow.

Authors:  Arash Alizadeh Yegani; Erkan Maytalman; Ilknur Kozanoglu; Menderes Yusuf Terzi; Fazilet Aksu
Journal:  Iran J Basic Med Sci       Date:  2020-01       Impact factor: 2.699

8.  Aspiration, but not injection, decreases cultured equine mesenchymal stromal cell viability.

Authors:  Lynn B Williams; Keith A Russell; Judith B Koenig; Thomas G Koch
Journal:  BMC Vet Res       Date:  2016-03-07       Impact factor: 2.741

9.  Response to Intravenous Allogeneic Equine Cord Blood-Derived Mesenchymal Stromal Cells Administered from Chilled or Frozen State in Serum and Protein-Free Media.

Authors:  Lynn B Williams; Carmon Co; Judith B Koenig; Crystal Tse; Emily Lindsay; Thomas G Koch
Journal:  Front Vet Sci       Date:  2016-07-22

10.  Homing and Engraftment of Intravenously Administered Equine Cord Blood-Derived Multipotent Mesenchymal Stromal Cells to Surgically Created Cutaneous Wound in Horses: A Pilot Project.

Authors:  Suzanne J K Mund; Eiko Kawamura; Awang Hazmi Awang-Junaidi; John Campbell; Bruce Wobeser; Daniel J MacPhee; Ali Honaramooz; Spencer Barber
Journal:  Cells       Date:  2020-05-08       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.